Donidalorsen Treatment in Children With Hereditary Angioedema — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Donidalorsen Treatment in Children With Hereditary Angioedema — Stella

Recruiting

Back to Hereditary Angioedema (HAE) trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(5 sites)

United States

Ionis Investigative Site, Santa Monica, California

Ionis Investigative Site, St Louis, Missouri

Ionis Investigative Site, Cincinnati, Ohio

Italy

Ionis Investigative Site, Milan

Spain

Ionis Investigative Site, Barcelona

Key details

Phase

Large-scale testing

Sponsor

Ionis Pharmaceuticals, Inc.

Enrollment target

~20 participants

Started

July 2026

Primary completion

June 2029

Age range

2 Years – 11 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov